Correlation Engine 2.0
Clear Search sequence regions


  • anthocyanin (1)
  • blood flow (2)
  • brain (2)
  • cyanidin (1)
  • heme (1)
  • ischemia (3)
  • isoform (1)
  • lipid (1)
  • nitric oxide (2)
  • thiol (1)
  • transient ischemia (1)
  • Sizes of these terms reflect their relevance to your search.

    This study investigated the effect of cyanidin-3-O-β-glucoside on an experimental model of partial/transient cerebral ischemia in the rats in order to verify the effectiveness of both pre- and posttreatments. Cyanidin-3-O-β-glucoside-pretreated rats were injected with 10 mg/Kg i.p. 1 h before the induction of cerebral ischemia; in posttreated rats, the same dosage was injected during reperfusion (30 min after restoring blood flow). Cerebral ischemia was induced by bilateral clamping of common carotid arteries for 20 min. Ischemic rats were sacrificed immediately after 20 min ischemia; postischemic reperfused animals were sacrificed after 3 or 24 h of restoring blood flow. Results showed that treatment with cyanidin increased the levels of nonproteic thiol groups after 24 h of postischemic reperfusion, significantly reduced the lipid hydroperoxides, and increased the expression of heme oxygenase and γ-glutamyl cysteine synthase; a significant reduction in the expression of neuronal and inducible nitric oxide synthases and the equally significant increase in the endothelial isoform were observed. Significant modifications were also detected in enzymes involved in metabolism of endogenous inhibitors of nitric oxide. Most of the effects were observed with both pre- and posttreatments with cyanidin-3-O-β-glucoside suggesting a role of anthocyanin in both prevention and treatment of postischemic reperfusion brain damage.

    Citation

    Claudia Di Giacomo, Rosaria Acquaviva, Rosa Santangelo, Valeria Sorrenti, Luca Vanella, Giovanni Li Volti, Nicolantonio D'Orazio, Angelo Vanella, Fabio Galvano. Effect of Treatment with Cyanidin-3-O-β-D-Glucoside on Rat Ischemic/Reperfusion Brain Damage. Evidence-based complementary and alternative medicine : eCAM. 2012;2012:285750


    PMID: 23008739

    View Full Text